These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 25267204

  • 1. [Managing of platelet transfusion refractoriness of haematological malignancies. Experience IPC-EFSAM].
    Dettori I, Ladaique P.
    Transfus Clin Biol; 2014 Nov; 21(4-5):207-9. PubMed ID: 25267204
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Platelet transfusion refractoriness.
    Hod E, Schwartz J.
    Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management.
    Panch SR, Guo L, Vassallo R.
    Blood Rev; 2023 Nov; 62():101135. PubMed ID: 37805287
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
    Wiita AP, Nambiar A.
    Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of platelet refractoriness in oncohematologic patients.
    Ferreira AA, Zulli R, Soares S, Castro Vd, Moraes-Souza H.
    Clinics (Sao Paulo); 2011 Oct; 66(1):35-40. PubMed ID: 21437433
    [Abstract] [Full Text] [Related]

  • 11. Detection and identification of platelet-associated alloantibodies by a solid-phase modified antigen capture enzyme-linked immunosorbent assay method and its correlation to platelet refractoriness in multiplatelet concentrate-transfused patients.
    Jain N, Sarkar S, Philip J.
    Immunohematology; 2014 Oct; 30(3):123-5. PubMed ID: 25695438
    [Abstract] [Full Text] [Related]

  • 12. Platelets as immunogens.
    Waters AH.
    Vox Sang; 1994 Oct; 67 Suppl 3():125-7. PubMed ID: 7975474
    [No Abstract] [Full Text] [Related]

  • 13. Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness.
    Saris A, Pavenski K.
    Transfus Med Rev; 2020 Oct; 34(4):250-257. PubMed ID: 33127210
    [Abstract] [Full Text] [Related]

  • 14. Recipient-derived HPA-1a antibodies: a cause of prolonged thrombocytopenia after unrelated donor stem cell transplantation.
    Lucas G, Culliford S, Green F, Sidra G, Calvert A, Green A, Harrison P, Harvey J, Allen D, Smillie D, Masurekar A, Marks D, Russell N, Massey E.
    Transfusion; 2010 Feb; 50(2):334-9. PubMed ID: 19874563
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Fetal/neonatal allo-immune thrombocytopenias: the unsolved questions].
    Kaplan C.
    Transfus Clin Biol; 2005 Jun; 12(2):131-4. PubMed ID: 15950890
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
    Amemiya Y.
    Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevention and management of platelet transfusion refractoriness.
    Novotny VM.
    Vox Sang; 1999 Sep; 76(1):1-13. PubMed ID: 9933848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.